In this report, the EMEA Immunoglobulin market is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2019 and 2025.
An immunoglobulin (Ig), also known as an antibody, is a protein used by the immune system to neutralize pathogens. There are various types of Igs that include IgA, IgD, IgE, IgG, and IgM. Igs find application in diagnosis and treatment of various diseases such as rheumatoid arthritis (RA), multiple sclerosis (MS), psoriasis, and cancer.
Increasing prevalence of pandemic diseases is expected to propel growth of EMEA immunoglobulins market over the forecast period. For instance, there have been 219,187 confirmed cases of COVID-19 with 31,855 deaths in the U.K. from Jan 31, 2020 to May 12, 2020, as reported to the World Health Organization. Moreover, increasing prevalence of cancer is also expected to aid in growth of the market. For instance, according to a study, ‘Projections of cancer prevalence in the United Kingdom, 2010-2040’, published in British Journal of Cancer, the number of people suffering from cancer in the U.K. is expected to increase from 2.5 million in 2015 to 4 million by 2030.
Antibody testing for Covid-19 is expected to offer lucrative growth opportunities for players in EMEA immunoglobulins market. For instance, in April 2020, The Robert Koch Institute, Germany, launched Covid-19 antibody testing in Germany. Similarly, Abbott Laboratories received Emergency CE mark for its SARS-CoV-2 IgG lab-based serology blood test on the Alinity i system.
Major players in the market are focused on adopting various strategies to enhance their market share. For instance, in November 2019, ADMA Biologics, Inc. presented its corporate overview at the Jefferies 2019 London Healthcare Conference, held at the Waldorf Hilton London, UK.
Key Takeaways
- Increasing prevalence of pandemic diseases to augment growth of EMEA immunoglobulins market over the forecast period
- Major players in the market are focused on adopting partnership strategies to expand their product portfolio. For instance, in April 2020, CSL Behring partnered with SAB Biotherapeutics for development of SAB-185, a COVID-19 therapeutic candidate, a high-potency immunotherapy delivering human polyclonal antibodies targeted to SARS-CoV-2.
- Major players operating in EMEA immunoglobulins market include, ADMA Biologics, Inc., Baxter international Inc., Bayer Healthcare, CSL Behring, BioScrip, Inc., Biotest AG, Boya Bio, China Biologics Products, Inc., China National Pharmaceutical Group, CSL Ltd., CTBB, Grifols S.A, Hualan Biological Engineering Inc., Jiade Bio, Kedrion Biopharma Inc, LFB Group, Octapharma AG, Omrix Biopharmaceuticals Ltd., Option Care Enterprises, Inc., Shanghai RAAS Blood Products Co., Ltd., Shanxi Kangbao Biological, Shire (Baxalta), Shuanglin Bio Pharm, Sichuan Yuanda Shuyang Pharmaceutical, and Weilun Bio
Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Immunoglobulin for these regions, from 2018 to 2025 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.
EMEA Immunoglobulin market competition by top manufacturers/players, with Immunoglobulin sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Company
Baxter
CSL
Grifols
Octapharma
Biotest
China National Pharmaceutical Group
CTBB
Hualan Bio
RAAS
Shanxi Kangbao Biological
Shuanglin Bio Pharm
Sichuan Yuanda Shuyang Pharmaceutical
Boya Bio
Jiade Bio
Weilun Bio
On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Intramuscular Injection Human Immunoglobulin
Intravenous Injection Human Immunoglobulin
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Immunoglobulin for each application, including
Prevention Of Measles
Infectious Hepatitis
Primary Immunoglobulin Deficiency
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
EMEA (Europe, Middle East and Africa) Immunoglobulin Market Report 2019
1 Immunoglobulin Overview
1.1 Product Overview and Scope of Immunoglobulin
1.2 Classification of Immunoglobulin
1.2.1 EMEA Immunoglobulin Market Size (Sales) Comparison by Type (2014-2024)
1.2.2 EMEA Immunoglobulin Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Intramuscular Injection Human Immunoglobulin
1.2.4 Intravenous Injection Human Immunoglobulin
1.3 EMEA Immunoglobulin Market by Application/End Users
1.3.1 EMEA Immunoglobulin Sales (Volume) and Market Share Comparison by Application (2014-2024
1.3.2 Prevention Of Measles
1.3.3 Infectious Hepatitis
1.3.4 Primary Immunoglobulin Deficiency
1.4 EMEA Immunoglobulin Market by Region
1.4.1 EMEA Immunoglobulin Market Size (Value) Comparison by Region (2014-2024)
1.4.2 Europe Status and Prospect (2014-2024)
1.4.3 Middle East Status and Prospect (2014-2024)
1.4.4 Africa Status and Prospect (2014-2024)
1.5 EMEA Market Size (Value and Volume) of Immunoglobulin (2014-2024)
1.5.1 EMEA Immunoglobulin Sales and Growth Rate (2014-2024)
1.5.2 EMEA Immunoglobulin Revenue and Growth Rate (2014-2024)
2 EMEA Immunoglobulin Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Immunoglobulin Market Competition by Players/Manufacturers
2.1.1 EMEA Immunoglobulin Sales Volume and Market Share of Major Players (2014-2019)
2.1.2 EMEA Immunoglobulin Revenue and Share by Players (2014-2019)
2.1.3 EMEA Immunoglobulin Sale Price by Players (2014-2019)
2.2 EMEA Immunoglobulin (Volume and Value) by Type/Product Category
2.2.1 EMEA Immunoglobulin Sales and Market Share by Type (2014-2019)
2.2.2 EMEA Immunoglobulin Revenue and Market Share by Type (2014-2019)
2.2.3 EMEA Immunoglobulin Sale Price by Type (2014-2019)
2.3 EMEA Immunoglobulin (Volume) by Application
2.4 EMEA Immunoglobulin (Volume and Value) by Region
2.4.1 EMEA Immunoglobulin Sales and Market Share by Region (2014-2019)
2.4.2 EMEA Immunoglobulin Revenue and Market Share by Region (2014-2019)
2.4.3 EMEA Immunoglobulin Sales Price by Region (2014-2019)
3 Europe Immunoglobulin (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Immunoglobulin Sales and Value (2014-2019)
3.1.1 Europe Immunoglobulin Sales Volume and Growth Rate (2014-2019)
3.1.2 Europe Immunoglobulin Revenue and Growth Rate (2014-2019)
3.2 Europe Immunoglobulin Sales and Market Share by Type
3.3 Europe Immunoglobulin Sales and Market Share by Application
3.4 Europe Immunoglobulin Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Immunoglobulin Sales Volume by Countries (2014-2019)
3.4.2 Europe Immunoglobulin Revenue by Countries (2014-2019)
3.4.3 Germany Immunoglobulin Sales and Growth Rate (2014-2019)
3.4.4 France Immunoglobulin Sales and Growth Rate (2014-2019)
3.4.5 UK Immunoglobulin Sales and Growth Rate (2014-2019)
3.4.6 Russia Immunoglobulin Sales and Growth Rate (2014-2019)
3.4.7 Italy Immunoglobulin Sales and Growth Rate (2014-2019)
3.4.8 Benelux Immunoglobulin Sales and Growth Rate (2014-2019)
4 Middle East Immunoglobulin (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Immunoglobulin Sales and Value (2014-2019)
4.1.1 Middle East Immunoglobulin Sales Volume and Growth Rate (2014-2019)
4.1.2 Middle East Immunoglobulin Revenue and Growth Rate (2014-2019)
4.2 Middle East Immunoglobulin Sales and Market Share by Type
4.3 Middle East Immunoglobulin Sales and Market Share by Application
4.4 Middle East Immunoglobulin Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Immunoglobulin Sales Volume by Countries (2014-2019)
4.4.2 Middle East Immunoglobulin Revenue by Countries (2014-2019)
4.4.3 Saudi Arabia Immunoglobulin Sales and Growth Rate (2014-2019)
4.4.4 Israel Immunoglobulin Sales and Growth Rate (2014-2019)
4.4.5 UAE Immunoglobulin Sales and Growth Rate (2014-2019)
4.4.6 Iran Immunoglobulin Sales and Growth Rate (2014-2019)
5 Africa Immunoglobulin (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Immunoglobulin Sales and Value (2014-2019)
5.1.1 Africa Immunoglobulin Sales Volume and Growth Rate (2014-2019)
5.1.2 Africa Immunoglobulin Revenue and Growth Rate (2014-2019)
5.2 Africa Immunoglobulin Sales and Market Share by Type
5.3 Africa Immunoglobulin Sales and Market Share by Application
5.4 Africa Immunoglobulin Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Immunoglobulin Sales Volume by Countries (2014-2019)
5.4.2 Africa Immunoglobulin Revenue by Countries (2014-2019)
5.4.3 South Africa Immunoglobulin Sales and Growth Rate (2014-2019)
5.4.4 Nigeria Immunoglobulin Sales and Growth Rate (2014-2019)
5.4.5 Egypt Immunoglobulin Sales and Growth Rate (2014-2019)
5.4.6 Algeria Immunoglobulin Sales and Growth Rate (2014-2019)
6 EMEA Immunoglobulin Manufacturers/Players Profiles and Sales Data
6.1 Company
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Immunoglobulin Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Company Immunoglobulin Sales, Revenue, Price and Gross Margin (2014-2019)
6.1.4 Main Business/Business Overview
6.2 Baxter
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Immunoglobulin Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Baxter Immunoglobulin Sales, Revenue, Price and Gross Margin (2014-2019)
6.2.4 Main Business/Business Overview
6.3 CSL
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Immunoglobulin Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 CSL Immunoglobulin Sales, Revenue, Price and Gross Margin (2014-2019)
6.3.4 Main Business/Business Overview
6.4 Grifols
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Immunoglobulin Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Grifols Immunoglobulin Sales, Revenue, Price and Gross Margin (2014-2019)
6.4.4 Main Business/Business Overview
6.5 Octapharma
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Immunoglobulin Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Octapharma Immunoglobulin Sales, Revenue, Price and Gross Margin (2014-2019)
6.5.4 Main Business/Business Overview
6.6 Biotest
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Immunoglobulin Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Biotest Immunoglobulin Sales, Revenue, Price and Gross Margin (2014-2019)
6.6.4 Main Business/Business Overview
6.7 China National Pharmaceutical Group
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Immunoglobulin Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 China National Pharmaceutical Group Immunoglobulin Sales, Revenue, Price and Gross Margin (2014-2019)
6.7.4 Main Business/Business Overview
6.8 CTBB
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Immunoglobulin Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 CTBB Immunoglobulin Sales, Revenue, Price and Gross Margin (2014-2019)
6.8.4 Main Business/Business Overview
6.9 Hualan Bio
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Immunoglobulin Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Hualan Bio Immunoglobulin Sales, Revenue, Price and Gross Margin (2014-2019)
6.9.4 Main Business/Business Overview
6.10 RAAS
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Immunoglobulin Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 RAAS Immunoglobulin Sales, Revenue, Price and Gross Margin (2014-2019)
6.10.4 Main Business/Business Overview
6.11 Shanxi Kangbao Biological
6.12 Shuanglin Bio Pharm
6.13 Sichuan Yuanda Shuyang Pharmaceutical
6.14 Boya Bio
6.15 Jiade Bio
6.16 Weilun Bio
7 Immunoglobulin Manufacturing Cost Analysis
7.1 Immunoglobulin Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Immunoglobulin
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Immunoglobulin Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Immunoglobulin Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 EMEA Immunoglobulin Market Forecast (2019-2024)
11.1 EMEA Immunoglobulin Sales, Revenue and Price Forecast (2019-2024)
11.1.1 EMEA Immunoglobulin Sales and Growth Rate Forecast (2019-2024)
11.1.2 EMEA Immunoglobulin Revenue and Growth Rate Forecast (2019-2024)
11.1.3 EMEA Immunoglobulin Price and Trend Forecast (2019-2024)
11.2 EMEA Immunoglobulin Sales, Revenue and Growth Rate Forecast by Region (2019-2024)
11.3 Europe Immunoglobulin Sales, Revenue and Growth Rate Forecast by Region (2019-2024)
11.4 Middle Eastt Immunoglobulin Sales, Revenue and Growth Rate Forecast by Region (2019-2024)
11.5 Africa Immunoglobulin Sales, Revenue and Growth Rate Forecast by Region (2019-2024)
11.6 EMEA Immunoglobulin Sales Forecast by Type (2019-2024)
11.7 EMEA Immunoglobulin Sales Forecast by Application (2019-2024)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
Request Discount 
Inquire Before Buy
